ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Seattle Genetics Completes Acquisition of Cascadian Therapeutics
March 12, 2018Seattle Genetics, Inc. (Nasdaq:SGEN) today announced it has completed its previously announced acquisition of Cascadian Therapeutics, Inc -
Seattle Genetics Snaps Up Cascadian in $614M Buyout Deal
February 01, 2018The year’s merger-and-acquisition trend continues. Today, the last day of January, Bothell, Washington-based Seattle Genetics announced it is buying Seattle-based Cascadian Therapeutics for about $614 million. -
Cascadian Therapeutics Announces 2018 Outlook and Recent Progress
January 05, 2018Clinical Phase Biopharmaceuticals company Cascadian Therapeutics today announced a review of recent advances in tucatinib, an investigational oral small molecule kinase inhibitor
Pharma Sources Insight January 2025
